Arena Pharmaceuticals Inc (ARNA)

60.32 +0.95  +1.60% NASDAQ Aug 5, 11:53 USD
View Full Chart
Price Chart
View All ARNA News


View All Events


Date Type Description
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/11/2021 12:00 EST AGM 2020 Annual General Meeting
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/23/2021 Earnings Results Q4 2020 Earnings Results
02/23/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/09/2020 Earnings Results Q3 2020 Earnings Results
11/09/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/05/2020 16:30 EST Earnings Calls Q2 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
TOKE Cambria Cannabis ETF 3.16%
MJ ETFMG Alternative Harvest ETF 3.13%
DLRHX Delaware Healthcare R 3.10%
F00001553T AAM Biotechnology Opps 2020-1 F RE 2.54%
F0000162BO AAM Biotechnology Opp 15M CDA 2020-4 FCA 2.39%
F000016RTG AAM Biotechnology Opps 2021-1 CA 2.36%
SBIO ALPS Medical Breakthroughs ETF 2.33%
F000016H69 AAM Biotechnology Opp 15M CDA 2021-1 FCA 2.26%
KRXCX Kinetics Medical Adv C 1.78%
MJJ MicroSectors™ Cannabis ETN 1.33%
YOLO AdvisorShares Pure Cannabis ETF 1.09%
HQL Tekla Life Sciences Investors 0.93%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.